---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-286747"
form_type: "8-K"
ticker: "IKT"
cik: "0001750149"
company_name: "Inhibikase Therapeutics, Inc."
filed_at: "2026-06-29T10:05:21+00:00"
generated_at: "2026-06-29T10:10:23.117747+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Inhibikase stockholders approve 3M share increase under equity plan and director elections

## Summary
- Stockholders approved amendment to 2020 Equity Incentive Plan increasing authorized shares by 3,000,000.
- Certificate of incorporation amended to limit liability of certain officers as permitted by Delaware law.
- Arvind Kush (70.3M for) and Dennis Berman (64.1M for) elected as Class III directors to 2029 meeting.
- CohnReznick LLP ratified as independent auditor for fiscal 2026 with 106.9M votes for.
- Advisory vote on executive compensation passed; company will hold future say-on-pay votes annually.

## SEC filing metadata
- accession: 0001193125-26-286747
- form_type: 8-K
- ticker: IKT
- cik: 0001750149
- company_name: Inhibikase Therapeutics, Inc.
- filed_at: 2026-06-29T10:05:21+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750149/000119312526286747/0001193125-26-286747-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750149/000119312526286747/d68912d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-286747
- JSON: https://secwatch.observer/filing/0001193125-26-286747.json
- Plain text: https://secwatch.observer/filing/0001193125-26-286747.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.